Sub Banner Image

Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains Bullish

Equities

Stocktwits

·

·

Barchart

Axsome still plans to submit its AXS-05 drug to the U.S. FDA for approval.

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.